Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

mRNA vaccine in cancer therapy: Current advance and future outlook
Youhuai Li, Mina Wang, Xueqiang Peng, et al.
Clinical and Translational Medicine (2023) Vol. 13, Iss. 8
Open Access | Times Cited: 66

Showing 1-25 of 66 citing articles:

Cold and hot tumors: from molecular mechanisms to targeted therapy
Bo Wu, Bo Zhang, Bowen Li, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 34
Cascade Carrier‐Free Nanoparticles Forming In Situ Nanovaccines for Synergistic Photothermal‐Immunotherapy of Cancer
Chenlu Huang, Hanyong Wang, Xinyu Yang, et al.
Advanced Functional Materials (2024) Vol. 34, Iss. 29
Closed Access | Times Cited: 15
Nucleic acid-based drugs for patients with solid tumours
Sebastian G. Huayamares, David Loughrey, Hyejin Kim, et al.
Nature Reviews Clinical Oncology (2024) Vol. 21, Iss. 6, pp. 407-427
Closed Access | Times Cited: 11
mRNA vaccines in the context of cancer treatment: from concept to application
Qiang Fu, Xiaoming Zhao, Jinxia Hu, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access | Times Cited: 1
Expanding the Potential of Circular RNA (CircRNA) Vaccines: A Promising Therapeutic Approach
Tian Bu, Wenlong Yang, Jian Zhao, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 1, pp. 379-379
Open Access | Times Cited: 1
Nanostructured lipid carriers based mRNA vaccine leads to a T cell–inflamed tumour microenvironment favourable for improving PD-1/PD-L1 blocking therapy and long-term immunity in a cold tumour model
Carole Fournier, Marion Mercey-Ressejac, Valentin Dérangère, et al.
EBioMedicine (2025) Vol. 112, pp. 105543-105543
Open Access | Times Cited: 1
Overcoming immunotherapy resistance in gastric cancer: insights into mechanisms and emerging strategies
D.Y. Luo, Jing Zhou, Shuiliang Ruan, et al.
Cell Death and Disease (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 1
mRNA vaccine platforms: linking infectious disease prevention and cancer immunotherapy
Dariush Haghmorad, Majid Eslami, Niloufar Orooji, et al.
Frontiers in Bioengineering and Biotechnology (2025) Vol. 13
Open Access | Times Cited: 1
Recent Findings on Therapeutic Cancer Vaccines: An Updated Review
Sara Sheikhlary, David Humberto Lopez, Sophia Moghimi, et al.
Biomolecules (2024) Vol. 14, Iss. 4, pp. 503-503
Open Access | Times Cited: 7
mRNA vaccines: a new era in vaccine development
Shubhra Chandra, Jennifer C Wilson, David M. Good, et al.
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (2024) Vol. 32, Iss. 10, pp. 1543-1564
Open Access | Times Cited: 7
Nucleic acid cancer vaccines targeting tumor related angiogenesis. Could mRNA vaccines constitute a game changer?
Srdan Tadic, Alfredo Martı́nez
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 6
Recent advancements in cancer vaccines: A systematic review
Stuti Srivastava, Devendra Singh, Sunil Kumar Verma, et al.
Vacunas (English Edition) (2024) Vol. 25, Iss. 1, pp. 97-108
Closed Access | Times Cited: 5
Breaking barriers: Smart vaccine platforms for cancer immunomodulation
Mohammad Mahmoudi Gomari, Taha Ghantabpour, Nima Pourgholamamiji, et al.
Cancer Communications (2025)
Open Access
Biomimetic Nanoparticle Based Targeted mRNA Vaccine Delivery as a Novel Therapy for Glioblastoma Multiforme
Tanvir Ahmed, Kazi Tasnuva Alam
AAPS PharmSciTech (2025) Vol. 26, Iss. 3
Closed Access
Recent advances and perspectives on the development of circular RNA cancer vaccines
Zhaohui Gong, Wentao Hu, Chengwei Zhou, et al.
npj Vaccines (2025) Vol. 10, Iss. 1
Open Access
Immunogenicity and Protective Efficacy of an mRNA Vaccine Targeting HSV-2 UL41 in Mice
Tangwei Mou, Yu Zhao, Jie Jia, et al.
Vaccines (2025) Vol. 13, Iss. 3, pp. 271-271
Open Access
Neoantigen-based mRNA vaccine exhibits superior anti-tumor activity compared to synthetic long peptides in an in vivo lung carcinoma model
Cao Minh Nguyen, Trung Vu, Minh Nguyen Nguyen, et al.
Cancer Immunology Immunotherapy (2025) Vol. 74, Iss. 4
Open Access
Investigation of the impact of lipid nanoparticle compositions on the delivery and T cell response of circRNA vaccine
Yasir Alshehry, Xiang Liu, Yu Zhang, et al.
Journal of Controlled Release (2025), pp. 113617-113617
Closed Access
Identification of new immune target and signaling for cancer immunotherapy
S. P. Narote, Sharav Desai, Vipul P. Patel, et al.
Cancer Genetics (2025)
Closed Access
Peptide hydrogel platform encapsulating manganese ions and high-density lipoprotein nanoparticle-mimicking nanovaccines for the prevention and treatment of gastric cancer
Xu Huang, Hong Lin, Yufan Lv, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
Lipid nanoparticle mediated mRNA delivery in cancer immunotherapy
Gyati Shilakari Asthana, Saptarshee Bhattacharjee, Jitendra Kumar, et al.
Advances in immunology (2025)
Closed Access
The Role of STEAP1 in Prostate Cancer: Implications for Diagnosis and Therapeutic Strategies
Lingling Zhang, Xinyi Ren, Ran An, et al.
Biomedicines (2025) Vol. 13, Iss. 4, pp. 794-794
Open Access
Novel Strategies in Breast Cancer Management: from Treatment to Long-term Remission
S Habibi, Shabbou Bahramian, Saeedeh Zare Jalise, et al.
Critical Reviews in Oncology/Hematology (2025), pp. 104715-104715
Closed Access
Multi-disciplinary approaches paving the way for clinically effective peptide vaccines for cancer
Bansari A. Shah, James A. Holden, Jason C. Lenzo, et al.
npj Vaccines (2025) Vol. 10, Iss. 1
Open Access
mRNA vaccine development and applications: A special focus on tumors (Review)
Bangjie Chen, Yipin Yang, Xinyi Wang, et al.
International Journal of Oncology (2024) Vol. 65, Iss. 2
Closed Access | Times Cited: 4
Page 1 - Next Page

Scroll to top